×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| Supriya Lifescience Limited | 1,870.84 | 503.82 | 1,841.09 | 6.29 | 5,416 | 28.8 |
| SUN PHARMA ADVANCED RESEARCH C | 271.90 | -609.80 | 271.90 | -1.88 | 5384 | |
| SUVEN LIFE SCIENCES LTD. | 26.58 | -150.70 | 14.67 | -0.69 | 5147 |
Supriya Lifescience Limited, with Security Code 543434, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 105.1 | 142.3 | 132.0 | 140.1 | 140.1 | 158.2 | 160.6 | 166.1 | 185.6 | 184.1 |
| Expenses | 91.1 | 87.2 | 87.5 | 108.3 | 98.6 | 102.7 | 98.1 | 101.4 | 119.7 | 116.5 |
| Operating Profit | 14.0 | 55.0 | 44.5 | 31.8 | 41.5 | 55.5 | 62.5 | 64.7 | 66.0 | 67.6 |
| OPM % | 13.36% | 38.69% | 33.7% | 22.66% | 29.62% | 35.09% | 38.94% | 38.96% | 35.53% | 36.72% |
| Other Income | 2.6 | 2.0 | 2.9 | 2.5 | 3.1 | 2.2 | 2.2 | 2.5 | 2.1 | 3.0 |
| Interest | 1.0 | 0.7 | 0.8 | 0.5 | 0.5 | 0.6 | 0.3 | 0.4 | 0.5 | 0.4 |
| Depreciation | 3.0 | 3.0 | 4.0 | 4.0 | 4.0 | 3.9 | 4.7 | 4.7 | 5.0 | 6.1 |
| Profit before tax | 12.6 | 53.3 | 42.6 | 29.8 | 40.1 | 53.2 | 59.8 | 62.1 | 62.6 | 64.1 |
| Tax % | -24.7% | -28.3% | -33.1% | -19.8% | -25.7% | -30.5% | 25.3% | 25.6% | 25.2% | -21.2% |
| Net Profit | 9.5 | 38.2 | 28.5 | 23.9 | 29.8 | 36.9 | 44.6 | 46.1 | 46.8 | 50.4 |
| EPS in Rs | 1.18 | 4.75 | 3.54 | 2.97 | 3.7 | 4.59 | 5.54 | 5.71 | 5.82 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | -1% |
| TTM: | 45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 27% |
| 1 Year: | 97% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|